This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: StudyGroup_DIBASY_Trial_Enrollment_Group - XML Representation

Raw xml | Download

<Group xmlns="http://hl7.org/fhir">
  <id value="46117"/>
  <meta>
    <versionId value="23"/>
    <lastUpdated value="2025-03-15T21:15:02.941Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/study-group"/>
  </meta>
  <text>
    <status value="empty"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
    <valueMarkdown
                   value="StudyGroup: DIBASY Trial Enrollment Group [Database Entry: FHIR Group Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 46117. Revised 2022-05-28. Available at: https://fevir.net/resources/Group/46117. Computable resource at: https://fevir.net/resources/Group/46117#json."/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Joanne Dehnbostel"/>
    </valueContactDetail>
  </extension>
  <url value="https://fevir.net/resources/Group/46117"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="urn:ietf:rfc:3986"/>
    <value value="https://fevir.net/FOI/46117"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="StudyGroup_DIBASY_Trial_Enrollment_Group"/>
  <status value="active"/>
  <date value="2022-05-28T12:27:47.384Z"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="An enumerated group with a single characteristic referencing the StudyEligibilityCriteria."/>
  <useContext>
    <code>
      <system value="https://fevir.net/resources/CodeSystem/179423"/>
      <code value="evidence-communication"/>
      <display value="Evidence Communication"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="StudyGroup"/>
        <display value="StudyGroup"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <type value="person"/>
  <membership value="enumerated"/>
  <quantity value="60"/>
  <characteristic>
    <code>
      <text value="Eligibility Criteria"/>
    </code>
    <valueReference>🔗 
      <reference value="Group/172461"/>
      <type value="Group"/>
      <display
               value="StudyEligibilityCriteria: Eligibility Criteria for DIBASY Trial"/>
    </valueReference>
    <exclude value="false"/>
    <description
                 value="Meeting Study Eligibility Criteria April 27, 2009 to October 31, 2009"/>
    <period>
      <start value="2009-04-27"/>
      <end value="2009-10-31"/>
    </period>
  </characteristic>
</Group>